Marapharm Ventures Inc Stock Canadian Securities Exchange
Equities
CA56575M1086
Healthcare Facilities & Services
Sales 2020 | 2.27 3.12 | Sales 2021 | 3.15 4.34 | Capitalization | 10.06M 13.85M |
---|---|---|---|---|---|
Net income 2020 | -40M -55.06M | Net income 2021 | -8M -11.01M | EV / Sales 2020 | 13,592,488 x |
Net Debt 2020 | 5.3M 7.3M | Net Debt 2021 | 13.31M 18.32M | EV / Sales 2021 | 7,417,546 x |
P/E ratio 2020 |
-0.45
x | P/E ratio 2021 |
-1.08
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 71.26% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 20-11-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 20-10-07 |
1st Jan change | Capi. | |
---|---|---|
+54.73% | 282M | |
+34.02% | 255M | |
+47.09% | 197M | |
+52.50% | 128M | |
-32.30% | 126M | |
+96.07% | 110M | |
+7.69% | 95.9M | |
-42.86% | 95.71M | |
+150.00% | 75.33M |